Englewood Health News

First-in-US Varicose Vein VEINRESET Trial Seeking Patients

Englewood Health is the first and only facility in North America to enroll patients in this trial.

November 14, 2023 — The Center for Vein Disease at Englewood Health, part of Englewood Health’s Vascular Surgery department, is seeking patients with symptomatic varicose veins for a new clinical trial called the Sonovein VEINRESET Trial.

The Sonovein device used for the trial employs HIFU (High Intensity Focused Ultrasound) to target and seal abnormal veins. This is the next evolution of a completely in-office, non-invasive, through-the-skin method of treating vein disease. For patients whose veins are conducive to this form of treatment, there may be advantages, including no incisions, guidewires, chemicals, or scars, and patients can resume normal activities immediately after the procedure.

Learn more

Other links or resources

Read related stories

Share This